279 related articles for article (PubMed ID: 12373428)
1. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development.
Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428
[TBL] [Abstract][Full Text] [Related]
2. Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction.
Rothman RB; Elmer GI; Shippenberg TS; Rea W; Baumann MH
Ann N Y Acad Sci; 1998 May; 844():59-74. PubMed ID: 9668665
[TBL] [Abstract][Full Text] [Related]
3. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
Rothman RB; Glowa JR
Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
[TBL] [Abstract][Full Text] [Related]
4. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
Koeltzow TE; Vezina P
Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior.
Doron R; Fridman L; Yadid G
Neuroreport; 2006 Oct; 17(15):1633-6. PubMed ID: 17001283
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
9. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
10. Research issues related to development of medications for treatment of cocaine addiction.
Klein M
Ann N Y Acad Sci; 1998 May; 844():75-91. PubMed ID: 9668666
[TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.
Hummel M; Unterwald EM
J Cell Physiol; 2002 Apr; 191(1):17-27. PubMed ID: 11920678
[TBL] [Abstract][Full Text] [Related]
12. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
13. A review of the effects of dopaminergic agents in humans: implications for medication development.
Rothman RB
NIDA Res Monogr; 1994; 145():67-87. PubMed ID: 8742808
[No Abstract] [Full Text] [Related]
14. Dopamine-dependent and dopamine-independent actions of cocaine as revealed by brain thermorecording in freely moving rats.
Kiyatkin EA; Brown PL
Eur J Neurosci; 2005 Aug; 22(4):930-8. PubMed ID: 16115216
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats.
Sizemore GM; Davies HM; Martin TJ; Smith JE
Drug Alcohol Depend; 2004 Mar; 73(3):259-65. PubMed ID: 15036548
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
Desai RI; Neumeyer JL; Bergman J; Paronis CA
Behav Pharmacol; 2007 Dec; 18(8):745-54. PubMed ID: 17989512
[TBL] [Abstract][Full Text] [Related]
19. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
[TBL] [Abstract][Full Text] [Related]
20. [Cocaine and crack addiction: a growing public health problem].
Haas C; Karila L; Lowenstein W
Bull Acad Natl Med; 2009 Apr; 193(4):947-62; discussion 962-3. PubMed ID: 20120283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
